Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and infectious diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate ...

Read More
06 December 2022

ABG oncology seminar, November 23, 2022 – presentation

Read More
24 November 2022

Nykode Therapeutics – 3Q 2022 Financial Results – presentation

Read More
23 November 2022

Nykode Therapeutics reports 3Q 2022 Financial Results

Read More
23 November 2022

Nykode Therapeutics to announce financial results for the third ...

Read More
16 November 2022

Nykode Therapeutics presents additional efficacy analysis in Phase 2 ...

Read More
07 November 2022

Credit Suisse 31st Annual Healthcare conference, 2022 – presentation

Read More
07 November 2022

Nykode Therapeutics to present at two upcoming investor conferences ...

Read More
07 November 2022

Nykode Therapeutics to Present a Poster on Interim Results from the ...

Read More
28 October 2022